key: cord-0899269-m33r86rt
authors: Moon, Hui jeong; Kim, Kyunghoon; Kang, Eun Kyeong; Yang, Hyeon-Jong; Lee, Eun
title: Prediction of COVID-19-related Mortality and 30-Day and 60-Day Survival Probabilities Using a Nomogram
date: 2021-08-26
journal: J Korean Med Sci
DOI: 10.3346/jkms.2021.36.e248
sha: f16e748e564a7ccaff00350b6e1c158b7b149cee
doc_id: 899269
cord_uid: m33r86rt

BACKGROUND: Prediction of mortality in patients with coronavirus disease 2019 (COVID-19) is a key to improving the clinical outcomes, considering that the COVID-19 pandemic has led to the collapse of healthcare systems in many regions worldwide. This study aimed to identify the factors associated with COVID-19 mortality and to develop a nomogram for predicting mortality using clinical parameters and underlying diseases. METHODS: This study was performed in 5,626 patients with confirmed COVID-19 between February 1 and April 30, 2020 in South Korea. A Cox proportional hazards model and logistic regression model were used to construct a nomogram for predicting 30-day and 60-day survival probabilities and overall mortality, respectively in the train set. Calibration and discrimination were performed to validate the nomograms in the test set. RESULTS: Age ≥ 70 years, male, presence of fever and dyspnea at the time of COVID-19 diagnosis, and diabetes mellitus, cancer, or dementia as underling diseases were significantly related to 30-day and 60-day survival and mortality in COVID-19 patients. The nomogram showed good calibration for survival probabilities and mortality. In the train set, the areas under the curve (AUCs) for 30-day and 60-day survival was 0.914 and 0.954, respectively; the AUC for mortality of 0.959. In the test set, AUCs for 30-day and 60-day survival was 0.876 and 0.660, respectively, and that for mortality was 0.926. The online calculators can be found at https://koreastat.shinyapps.io/RiskofCOVID19/. CONCLUSION: The prediction model could accurately predict COVID-19-related mortality; thus, it would be helpful for identifying the risk of mortality and establishing medical policies during the pandemic to improve the clinical outcomes.

Since December 2019, coronavirus disease 2019 has spread worldwide, without decreasing trend. While 80% of COVID-19 patients have a mild clinical course, 1 an unexpected increase in the number of deaths related to COVID-19 have resulted in an overwhelming medical burden in some areas. The ongoing pandemic has generated serious socioeconomic and healthcare problems due to the high mortality, especially in high-risk groups, and large number of patients in areas with limited medical resources. The overwhelming number of patients with COVID-19 infection combined with high-risk individuals for mortality makes it difficult to control the COVID-19 pandemic. Therefore, prediction of individualized risks for COVID-19 mortality is essential for estimating the severity of the clinical course of the disease. This would help in classifying the high-risk groups, which would help improve survival rates related with COVID-19.

COVID-19 mortality varies across countries ranging 1.4-4. 3%, but the number of deaths due to COVID-19 is higher than that due to other respiratory viral infections, such as seasonal influenza. 2 - 5 The individualized prediction of COVID-19-related mortality is important for prioritizing patients with a high risk of mortality in terms of the allocation of limited medical resources.

Previous studies on the estimation of severity and mortality of COVID-19 showed diverse results, with the identification of a limited number of predictors, such as age and sex. 6 -10 Age and underlying diseases are known factors associated with higher risks of mortality in patients with 2, 6, 7, 11, 12 which is partially related with increased severity and susceptibility to 14 However, heterogeneity in age and underlying diseases could affect COVID-19-related mortality, and therefore, findings from previous studies were inconclusive. 2, 6, 8, 9 In other studies, laboratory or radiologic findings were included in the factors predicting severity or mortality associated with However, data on these factors are available for a limited number of COVID-19 patients in clinical settings and it takes time to obtain the results of laboratory and radiological examinations, thereby delaying the prediction of mortality and severity in patients with In this study, we investigated the baseline characteristics of patients with COVID-19 and developed nomograms for predicting the probabilities of COVID-19-related mortality and 30day and 60-day survival using data obtained at the time of admission, including individual's underlying diseases.

The present study enrolled 5,626 confirmed cases of COVID-19 from the nationwide multicenter study between February 1 and April 30, 2020. During the study period, all confirmed cases of COVID-19 in South Korea were included since all patients were hospitalized regardless of their clinical presentation. Patients were followed-up until the end of their hospital stay. During the hospital stay, all patients were monitored by the Korea Disease Control & Prevention Agency of the National Medical Center; the database of information on patients with COVID-19 could be obtained from this agency. COVID-19 was confirmed via real-time reverse transcription-polymerase chain reaction assays using nasal and pharyngeal swab samples in accordance with the World Health Organization guidelines. 20,21 Data on baseline characteristics, such as age, sex, date of death, symptoms at the time of admission due to COVID-19, underlying diseases, and clinical severity were obtained retrospectively and anonymously under the leadership of the Central Disease Control Headquarters of South Korea. Height and weight of each patient were measured at the time of admission for treatment of COVID-19. Information on underlying diseases was collected by the doctors at the time of admission, by questioning the patients regarding the presence or history of any underlying disease.

Data on baseline characteristics, such as age, sex, height, and weight were obtained at the time of admission. Data on age were obtained in the form of age groups, using intervals of 10 years, but not individual age. Body mass index (BMI, kg/m 2 ) were calculated using each patient' height and weight due to the significant effect of BMI on health outcome in patients with Clinical manifestations at the time of admission included fever, defined as a body temperature of > 37.5°C; cough; sputum; sore throat; rhinorrhea; myalgia; fatigue; dyspnea; headache; altered consciousness; vomiting/nausea; and diarrhea. Underlying diseases included diabetes mellitus (DM), hypertension, heart failure, cardiovascular diseases, asthma, chronic obstructive pulmonary disease (COPD), chronic kidney disease, cancer, chronic liver disease, rheumatoid/ autoimmune disease, and dementia. The severity of COVID-19 was classified as mild, moderate, or severe as follows; mild, no interference with daily life or interference with daily life but no need for oxygen therapy during illness; moderate, requirement of oxygen via diverse routes (use of nasal cannula, oxygen mask, or non-invasive ventilator care); and severe, application of invasive ventilator care, multi-organ failure/ECMO use, or death.

Chi-square or Fisher's exact tests were performed to test the association between two nominal variables. Continuous variables were compared using the t-test or Welch t-test. The Mantel-Haenszel χ 2 test was used to test the correlation between two ordinal variables or between dichotomous and ordinal variables.

From the total population, 4,426 patients were included in the prediction model after excluding 1,200 patients with any missing information on the variables. The mortality rate of the excluded patients was 9.42% (n = 113). Logistic regression analyses and a Cox proportional hazards models were used to construct a well-calibrated and discriminative nomogram for predicting mortality as well as 30-day and 60-day survival probabilities.

Cox proportional hazard equation applied in the present study was as follows: To validate the models, the total population was randomized into the train and test sets at a ratio of 7:3. The balance between the two sets was checked using through the χ 2 test, and no significant differences were observed in all variables. To construct the logistic regression model, we obtained crude odds ratios (ORs) via univariate logistic regression analysis of the train set. We constructed a multivariate logistic model by including variables with P values < 0.2 in the univariate analysis and those with the lowest Akaike information criterion using the backward stepwise approach. 23 Finally, we obtained the final prediction model after extracting insignificant variables. The validation of the logistic regression model was checked by the calibration curve and area under the curve (AUC) in the test set. The same approach was used for the construction of a Cox proportional hazards model. The validation of the Cox proportional hazards model was checked using Harrell's C-index, time dependent AUCs, and calibration curves. The constructed models can be used on the web-based risk calculator (https://koreastat.shinyapps.io/RiskofCOVID19/).

Overall, statistical analyses were performed using the R programming language and environment version 4.0.2 (R Foundation for Statistical Computing, Vienna, Austria). P values < 0.05 was considered statistically significant.

This study was approved by the Institutional Review Board (IRB) of Chonnam National University Hospital (IRB No. CNUH-2020-303) and the Korea Disease Control and Prevention Agency. The need for informed consent was waived due to the retrospective nature of the study.

The present study included 5,626 confirmed COVID-19 cases. Prediction of COVID-19-related Mortality 

The most common symptom of COVID-19 was cough (22.60%) in all age groups, followed by sputum (15.63%), except among those in the 0-9 years group (Supplementary Table 1 ). Fever was more common in children (18.84% in the 0-9 years group vs. 13.26-15 .64% in other groups), whereas dyspnea was more common in the elderly, especially in those older than 70 years (14.42% in the older than 70 years group vs. 1.45-8.09% in other groups).

The prevalence of severe COVID-19 was the highest in patients with dementia (33.93%), followed by those with heart failure (33.90%) and chronic kidney disease (32.73%) (Supplementary Table 2 ). Similar to the prevalence of severe COVID-19, COVID-19-related mortality was the highest in patients with dementia (33.48%) (Supplementary Table 3 ).

There was linear correlation between age and COVID-19 severity (Supplementary Table 4 ). The prevalence of severe COVID-19 was the highest in elderly people, especially those aged over 70 years.

The prevalence of some underlying diseases, such as hypertension, dementia, and cancer, was the highest in individuals older than 70 years (Supplementary Table 5 ), whereas that of rheumatoid or autoimmune diseases was the highest in patients aged 50-59 years.

To identify potential factors that could predict COVID-19-related mortality, univariate and multivariate logistic regression analyses were performed, as indicated in Table 2 . The following factors showed significant associations with COVID-19-related mortality: age ≥ 70 years; male; the presence of fever and dyspnea at the time of diagnosis; and underlying diseases such as DM, cancer, and dementia. The same predictive factors were identified in the final Cox proportional hazard model for 30-day and 60-day survival in patients with COVID-19 ( Table 3) .

To identify high-risk patients, we constructed a predictive nomogram for mortality due to COVID-19 (Fig. 1) . Points were assigned to patients based on age, sex, presence of specific symptoms including fever and dyspnea at the time of diagnosis of COVID-19, and the presence of specific underlying diseases (DM, cancer, and dementia), with a vertical line to the "Points" scale at the top of the nomogram (Fig. 1A) . The actual and predicted mortalities due to COVID-19 were similar, and the calibration plot showed a mean absolute error of 0.006 (Fig. 1B) , suggesting that the model was acceptable. Fig. 1C shows that the under the receiver operating curve (ROC) for COVID-19-related mortality was 0.926.

shift from the perfect fit, with a good correlation between the predicted and observed values in the study population ( Fig. 2B and C) . The AUCs for 30-day and 60-day survival probability in patients with COVID-19 in the train set were 0.914 and 0.954, respectively ( Fig. 2D and E) . In the test set, the AUC for mortality was 0.926 ( Fig. 1) and AUCs for 30-day and 60-day survival were 0.876 and 0.660, respectively (Fig. 2) .

Even after a year post the emergence of COVID-19, severe cases of COVID-19 have caused socioeconomic and medical problems due to high mortality, especially in limited medical resource settings. Therefore, prediction of mortality early in the clinical course is essential in COVID-19 patients to stratify patients requiring intensive monitoring and aggressive therapy, thereby improving clinical outcomes. In the present study, we identified the predictive factors (4.25-16.50 ) < 0.001 COVID-19 = coronavirus disease 2019, OR = odds ratio, CI = confidence interval, aOR = adjusted odds ratio, DM = diabetes mellitus, COPD = chronic obstructive pulmonary disease. a of COVID-19-related mortality using a nomogram that was validated using calibration plots and ROC curves. The prognostic factors included age ≥ 70 years; male sex; presence of fever and dyspnea at the time of COVID-19 diagnosis; and DM, cancer, and dementia as underlying diseases; these factors can be easily evaluated in the early phase of diagnosis without any additional tests. In addition, we investigated the factors associated with 30-day and 60-day survival in patients with COVID-19; the same prognostic factors were identified. Our findings can help guide policy makers on medical resource allocation in the uncontrolled COVID-19 epidemic era, thereby, improving public health outcomes. Our results would be more useful even in medium-or low-income countries with limited resources for diagnostic purposes.

Although various scoring systems can predict COVID-19-related mortality, we used a nomogram with calibration and discrimination for validation in this study, thereby enabling individualized and evidence-based risk estimation. Previous studies have suggested nomograms for predicting the risk of severe (2.69-7.36) < 0.001 HR = hazard ratio, CI = confidence interval, DM = diabetes mellitus, COPD = chronic obstructive pulmonary disease. a using diverse laboratory findings, clinical features, and chest computed tomography (CT) findings. 15 -19,24,25 In the present study, we considered age, sex, body mass index, symptoms at the time of COVID-19 diagnosis, and underlying diseases for the prediction model as these parameters can be obtained in the early clinical course. This can be very helpful for identifying patients at risk of mortality at the time of COVID-19 diagnosis. In addition, the AUC for the prediction for COVID-19-related mortality in the present study was the highest compared to those in other previous studies, except for one that included chest CT findings as a predictive factor for severe COVID-19 (Supplementary Table 6 ). Significant laboratory markers, such as C-reactive protein, could be helpful for predicting the clinical course and outcomes of COVID-19 by reflecting the degree of inflammation. 19 However, we did not include laboratory findings or imaging results as a limited number of patients underwent laboratory and imaging examinations in our study. Thus, our prediction model can be easily applied to predict the mortality of COVID-19 even in low-and middle-income countries. Older age is known as a risk factor of COVID-19-related mortality, although the cut-off differs according to study populations. In the present study, the AUC for COVID19-related 30-day survival was excellent, whereas that for COVID-19-related 60-day survival was poor in the test set. These results might suggest that the prediction model based on age, sex, symptoms at the time of COVID-19 diagnosis, and underlying diseases would be appropriate for the prediction of COVID-19-related shortterm survival. However, more delicate variables, reflecting clinical courses and laboratory findings, might be needed for better prediction of COVID-19-related long-term survival.

There are some limitations to our study. The sample size was considered to be limited because the study population was enrolled in the early period of the pandemic. However, previous studies on the prediction of COVID-19-related mortality/severity included smaller samples than that in our study (Supplementary Table 6 ). 15 -18,25,37 -40 Since the appropriate therapeutic strategies had not been established during the early epidemic of COVID-19, the mortality in the present study was less affected by medications, including anti-viral agents, that can affect the clinical course of COVID-19. The present study included patients from care hospitals where patients with dementia were hospitalized. The prevalence of dementia differs across study populations. One study reported a 7.5% prevalence, 22 while some studies did not include dementia as one of the comorbidities of COVID-19. 2 Since comorbidities are affected by herd infections in specific institutions, consideration of the specific situations on mass infection is needed while interpreting the results of related studies. Although AUCs for COVID19-related 30-day and 60-day survival in the train set were excellent, AUC for 60-day survival in the test set showed poor accuracy. Although we performed internal validation by classifying the total population into the train and test sets, external validation of the results is also needed to confirm our results. The variants of SARS-CoV-2 and COVID-19 vaccination status were not considered in the prediction model in the present study due to availability of limited information at the time of data collection. The prediction models for COVID-19related mortality considering these factors can be developed after accumulation of sufficient information in the near future. The treatment strategies and clinical courses of COVID-19 prediction model were not included in the prediction model in the present study due to limitations in the available database. However, the results of the present study would be useful in predicting COVID-19-related mortality and in more efficient allocation of medical resources at an earlier stage. Finally, the present study was performed retrospectively, and therefore, validation using a prospective design is required to improve the statistical power of the results.

In conclusion, age ≥ 70 years, male sex, the presence of fever and dyspnea at the time of COVID-19 diagnosis, and DM, cancer, and dementia as underlying diseases are associated with an increased risk of COVID-19-related mortality, and these factors can be used for the prediction of 30-day and 60-day survival in COVID-19 patients. The results of the present study would be helpful in establishing therapeutic strategies for improving the clinical outcomes and guiding policy makers with regard to appropriate medical resource allocation.

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Prevalence of underlying diseases in died cases of COVID-19: a systematic review and meta-analysis

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, populationbased retrospective cohort study

Comparing COVID-19 and influenza presentation and trajectory

Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic

Age-specific mortality and immunity patterns of SARS-CoV-2

Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study

Sex differences in mortality rates and underlying conditions for COVID-19 deaths in England and Wales

The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age

Clinical characteristics of COVID-19: risk factors for early oxygen requirement after hospitalization

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region

Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: a national surveillance study

Covid-19 mortality: a matter of vulnerability among nations facing limited margins of adaptation

Risk factors of outcomes of COVID-19 patients in Korea: focus on early symptoms

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study

Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study

Nomogram to identify severe coronavirus disease 2019 (COVID-19) based on initial clinical and CT characteristics: a multi-center study

ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease

Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study

COVID-19 diagnosis -a review of current methods

Association of body mass index (BMI) with critical COVID-19 and inhospital mortality: a dose-response meta-analysis

Five myths about variable selection

A predicting nomogram for mortality in patients with COVID-19

Development and validation a nomogram for predicting the risk of severe COVID-19: a multi-center study in Sichuan, China

COVID-19 mortality risk for older men and women

Similarity in case fatality rates (CFR) of COVID-19/ SARS-COV-2 in Italy and China

Serology-informed estimates of SARS-CoV-2 infection fatality risk in

Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records

Hospital Authority SARS Collaborative Group. Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Death rate due to COVID-19 in Alzheimer's disease and frontotemporal dementia

COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients

Neurological features and outcome in COVID-19: dementia can predict severe disease

A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China

A predictive model for the severity of COVID-19 in elderly patients

A risk prediction model for evaluating the disease progression of COVID-19 pneumonia

An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital

Summary of the previous studies on the prediction of COVID-19 mortality and severe COVID-19Click here to view